Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 71, 2011 - Issue 7
Submit an article Journal homepage
201
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer

Abla A. Abou-ZeidDepartments of Clinical PathologyCorrespondence[email protected]
,
Amal Z. AzzamDepartments of Obstetrics and Gynecology
&
Nahla A. KamelDepartments of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Pages 542-547 | Received 13 Feb 2011, Accepted 06 May 2011, Published online: 06 Jul 2011

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jie Ruan, Peipei Xu, Wei Fan, Qiaoling Deng & Mingxia Yu. (2018) Quantitative assessment of aberrant P16 methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets. Cancer Management and Research 10, pages 3033-3046.
Read now

Articles from other publishers (10)

Chengfu Wu, Wenli Zheng, Jifa Zhang & Xingping He. (2022) Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-8.
Crossref
Tamojit Chaudhuri, K Govind Babu, KC Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, MC Suresh Babu, AH Rudresha, KN Lokesh & LK Rajeev. (2021) Selective cyclin-dependent kinase 4/6 inhibitors as anticancer drugs: Moving beyond hormone receptor-positive breast cancer. Indian Journal of Medical and Paediatric Oncology 40:01, pages 15-20.
Crossref
Francesco Schettini, Irene De Santo, Carmen G. Rea, Pietro De Placido, Luigi Formisano, Mario Giuliano, Grazia Arpino, Michelino De Laurentiis, Fabio Puglisi, Sabino De Placido & Lucia Del Mastro. (2018) CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. Frontiers in Oncology 8.
Crossref
Yi Jiang, Fangrong Yan, Li Liang, Yicong Wan, Jinsong Liu & Wenjun Cheng. (2016) Meta-analysis demonstrates no association between p16 ink4a promoter methylation and epithelial ovarian cancer. Archives of Gynecology and Obstetrics 295:3, pages 697-704.
Crossref
Erika Hamilton & Jeffrey R. Infante. (2016) Targeting CDK4/6 in patients with cancer. Cancer Treatment Reviews 45, pages 129-138.
Crossref
JIA-LI JIANG, GUI-LAN TIAN, SHU-JIAO CHEN, LI XU & HUI-QIN WANG. (2015) Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis. Experimental and Therapeutic Medicine 10:4, pages 1549-1555.
Crossref
Sandra Rodríguez-Rodero, Elías Delgado-Álvarez, Agustín F Fernández, Juan L Fernández-Morera, Edelmiro Menéndez-Torre & Mario F Fraga. (2014) Epigenetic alterations in endocrine-related cancer. Endocrine-Related Cancer 21:4, pages R319-R330.
Crossref
Mamadou Keita, Zhi-Qiang Wang, Jean-Francois Pelletier, Magdalena Bachvarova, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Anne-Marie Mes-Masson, Éric R. Paquet & Dimcho Bachvarov. (2013) Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression. Gynecologic Oncology 128:2, pages 356-363.
Crossref
Pedram Azimzadeh, Sara Romani, Seyed Reza Mohebbi, Touraj Mahmoudi, Mohsen Vahedi, Seyed Reza Fatemi, Narges Zali & Mohammad Reza Zali. (2012) Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genetics 205:10, pages 501-507.
Crossref
Annabelle L. Fonseca, Johan Kugelberg, Lee F. Starker, Ute Scholl, Murim Choi, Per Hellman, Göran Åkerström, Gunnar Westin, Richard P. Lifton, Peyman Björklund & Tobias Carling. (2012) Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes, Chromosomes and Cancer 51:10, pages 949-960.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.